Akcea Therapeutics, Inc. Retained Earnings
Akcea Therapeutics, Inc. had Retained Earnings of -$573.70 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-08-05
- 2020-06-30: Retained Earnings (Accumulated Deficit) -$573.70M.
- 2020-03-31: Retained Earnings (Accumulated Deficit) -$524.12M.
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$481.27M.
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$563.68M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2020-06-30 | -$573.70M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$524.12M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | -$481.27M 10-Q · filed 2020-08-05 | |
| 2019-09-30 | -$563.68M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | -$532.18M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$494.86M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$522.04M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$451.49M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$387.89M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$325.85M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | -$296.22M 10-K · filed 2019-03-01 | -$284.41M 10-K · filed 2018-02-28 |
| 2017-09-30 | -$261.05M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$246.96M 10-Q · filed 2017-08-09 | |
| 2016-12-31 | -$174.66M 8-K · filed 2018-09-18 |